Post Tagged with: "patents"

Do Patents Impede Medical Care and Innovation?

PLOS Medicine publishes a series of short pieces on the impact of patents on medical care and innovation, drawn in part from Canadians Richard Gold, James Obinski, and Sevil N-Marandi.

Read more ›

January 6, 2010 Comments are Disabled News

Beyond ACTA: Proposed EU – Canada Trade Agreement Intellectual Property Chapter Leaks

Canada's participation in the Anti-Counterfeiting Trade Agreement negotiations has understandably generated enormous public concern as leaked documents indicate that ACTA would have a dramatic impact on Canadian copyright law.  The U.S. has proposed provisions that would mandate a DMCA-style implementation for the WIPO Internet treaties and encourage the adoption of a three-strikes and you're out system to cut off access where there are repeated allegations of infringement.

Yet it would appear that ACTA is actually only part of the story.  Canada is also currently negotiating a Comprehensive Economic and Trade Agreement with the European Union.  The negotiations have been largely off the radar screen (and similarly secretive) with the first round of talks concluding in October in Ottawa. Intellectual property figures prominently in the agreement.  In fact, the EU proposal for the IP chapter has just leaked online and the document is incredibly troubling.  When combined with ACTA, the two agreements would render Canadian copyright law virtually unrecognizable as Canada would be required to undertake a significant rewrite of its law.  The notion of a "made-in-Canada" approach – already under threat from ACTA – would be lost entirely, replaced by a made-in-Washington-and-Brussels law.

What are some of the EU's demands?

  • Copyright term extension.  The current term of copyright law in Canada is life of the author plus 50 years.  This is consistent with the term requirements under the Berne Convention.  The EU is demanding that Canada add an additional 20 years by making the term life plus 70 years.
  • WIPO ratification. The EU is demanding that Canada respect the rights and obligations under the WIPO Internet treaties.  The EU only formally ratified those treaties this week.
  • Anti-circumvention provisions. The EU is demanding that Canada implement anti-circumvention provisions that include a ban on the distribution of circumvention devices.  There is no such requirement in the WIPO Internet treaties.
  • ISP Liability provisions.  The EU is demanding statutory provisions on ISP liability where they act as mere conduits, cache content, or host content.  ISPs would qualify for a statutory safe harbour in appropriate circumstances.  There is no three-strikes and you're out language (which presumably originates with the U.S.).
  • Enforcement provisions.  The EU is demanding that Canada establish a host of new enforcement provisions including measures to preserve evidence, ordering alleged infringers to disclose information on a wide range of issue, mandate disclosure of banking information in commercial infringement cases, allow for injunctive relief, and destruction of goods.  There is also a full section on new border measures requirements.
  • Resale rights.  The EU is demanding that Canada implement a new resale right that would provide artists with a royalty based on any resales of their works (subsequent to the first sale).
  • Making available or distribution rights.  The EU is demanding that Canada implement a distribution or making available right to copyright owners.

Read more ›

December 16, 2009 64 comments News

Panel Strikes Blow Against Business Method Patents in Canada

Appeared in the Toronto Star on May 25, 2009 as Two Clicks and You're Out, Panel Rules Appeared in the Ottawa Citizen on May 26, 2009 as System of Business Method Patents Could Face Rough Ride Most people think of patents in terms of legal protection for new technological inventions. […]

Read more ›

May 27, 2009 2 comments Columns Archive

Goldstein Introduces Patent Reform Bill To Ease Access To Medicines

For many years, countries such as Canada have avoided the uncomfortable truth that millions are dying in the developing world due partly to legal barriers that render access to medicines unaffordable.  In 2003, the World Trade Organization reached agreement designed to facilitate the export of medicines by opening the door to a compulsory licence for developing countries without manufacturing capabilities. Canada became an early adopter of the agreement by reforming the Patent Act to allow the Canadian Commissioner of Patents to issue a compulsory licence to a pharmaceutical company to allow for the manufacture and export of an eligible drug or medical device to an eligible importing country. Titled the Jean Chretien Pledge to Africa Act after the former Prime Minister’s commitment to development support in Africa, the reforms were touted as an illustration of Canadian leadership on development issues.  

My weekly technology law column (Toronto Star version, homepage version) notes that several years later, most agree the policy have been a near-total failure.  The law has only been used once and the company involved in the process found it so burdensome that it has vowed not to repeat it.  Moreover, other countries, including the European Union, the Netherlands, Switzerland, China, India and South Korea, have also implemented the WTO reforms in a manner that leaves the Canadian Access to Medicines Regime (CAMR) looking unduly restrictive and outdated by comparison.

Read more ›

April 14, 2009 2 comments Columns

Survey Finds Scientists Believe IP Protection Has Negative Effect on Biological Research

Nature Biotechnology has just published an article on the perceived effects of intellectual property protection for biological research.  The article involved a detailed survey of academic agricultural biologists on their perception of IP and research.  The authors' primary conclusion: Scientists believe that, contrary to the current consensus, proliferation of IP […]

Read more ›

January 23, 2009 6 comments News